Safety of selective serotonin reuptake inhibitors in pregnancy.
about
Increased risk of severe congenital heart defects in offspring exposed to selective serotonin-reuptake inhibitors in early pregnancy--an epidemiological study using validated EUROCAT data.Adverse drug reactions from psychotropic medicines in the paediatric population: analysis of reports to the Danish Medicines Agency over a decade.Prenatal exposure to serotonin reuptake inhibitors: a case reportAssociation Between Antidepressants Use During Pregnancy and Autistic Spectrum Disorders: A Meta-analysis.Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.Sertraline alters multidrug resistance phosphoglycoprotein activity in the mouse placenta and fetal blood-brain barrier.
P2860
Safety of selective serotonin reuptake inhibitors in pregnancy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety of selective serotonin reuptake inhibitors in pregnancy.
@en
Safety of selective serotonin reuptake inhibitors in pregnancy.
@nl
type
label
Safety of selective serotonin reuptake inhibitors in pregnancy.
@en
Safety of selective serotonin reuptake inhibitors in pregnancy.
@nl
prefLabel
Safety of selective serotonin reuptake inhibitors in pregnancy.
@en
Safety of selective serotonin reuptake inhibitors in pregnancy.
@nl
P1433
P1476
Safety of selective serotonin reuptake inhibitors in pregnancy
@en
P2093
Emilio J Sanz
P356
10.2174/157488606775252593
P577
2006-01-01T00:00:00Z